Controversial Aduhelm Alzheimer Drug's Quick Approval To Be Reviewed: US HHS Now Questions FDA's Decision U.S. HHS will investigate the controversial Aduhelm drug after FDA quickly approved Alzheimer's medicine. by Griffin Davis
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband